Jefferies Financial Group Reiterates Buy Rating for Smith & Nephew (LON:SN)

Key Points

• Jefferies Financial Group reaffirmed its “buy” rating on Smith & Nephew and maintained a GBX 1,500 price target, implying 42.59% upside from the previous close.
• Analyst sentiment is more cautious overall: Smith & Nephew has a consensus “hold” rating and an average target price of GBX 1,310, with three buy ratings and six hold ratings.
• Shares opened at GBX 1,052, below both the 50-day moving average of GBX 1,118.14 and the 200-day moving average of GBX 1,169.82; the company’s market capitalization is approximately £11.53 billion.

Smith & Nephew (LON:SN - Get Free Report)'s stock had its "buy" rating reaffirmed by Jefferies Financial Group in a research report issued to clients and investors on Friday, Digital Look reports. They presently have a GBX 1,500 target price on the stock. Jefferies Financial Group's target price would indicate a potential upside of 42.59% from the company's previous close.

Several other equities research analysts have also issued reports on SN. Royal Bank Of Canada decreased their price target on shares of Smith & Nephew from GBX 1,350 to GBX 1,250 and set a "sector perform" rating for the company in a research note on Thursday, August 6th. Shore Capital Group reissued a "buy" rating and set a GBX 1,000 price objective on shares of Smith & Nephew in a report on Tuesday, July 21st. Berenberg Bank decreased their target price on Smith & Nephew from GBX 1,300 to GBX 1,250 and set a "hold" rating for the company in a research report on Friday, August 14th. Citigroup lowered Smith & Nephew to a "buy" rating in a research note on Friday, July 10th. Finally, JPMorgan Chase & Co. dropped their price target on Smith & Nephew from GBX 1,438 to GBX 1,290 and set a "neutral" rating on the stock in a research report on Thursday, August 6th. Three analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of GBX 1,310.

Smith & Nephew Stock Performance

Shares of LON:SN opened at GBX 1,052 on Friday. The stock has a market cap of £11.53 billion, a P/E ratio of 37.88, a P/E/G ratio of 0.46 and a beta of 0.69. The business has a fifty day moving average of GBX 1,118.14 and a 200-day moving average of GBX 1,169.82. The company has a quick ratio of 0.84, a current ratio of 2.14 and a debt-to-equity ratio of 73.07.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source